CYP19A1 and breast carcinoma: Although Crotoxin activity in breast cancer cells had been previously demonstrated against MCF-7 and ER+ aromatase-overexpressing breast cancer (MCF-7aro) cells [10,19], this is the first time that this antitumoral activity is being explored for novel therapies targeting TNBC.